воскресенье, 22 мая 2016 г.

Investors Buy Regeneron Pharmaceuticals Inc (REGN) on Weakness on Insider Selling

Investors Buy Regeneron Pharmaceuticals Inc (REGN) on Weakness on Insider Selling


Investors purchased shares of Regeneron Pharmaceuticals Inc on weakness during trading on Thursday after an insider sold shares in the company. $165.67 million flowed into the stock on the tick-up and $114.32 million flowed out of the stock on the tick-down, for a money net flow of $51.35 million into the stock.



from Biotech News